Relevance of GERD in lung transplant patients

Current Gastroenterology Reports

Volumn 12, Issue 3, 2010, Pages 160-166

  Mertens, Veerle ^a   Dupont, Lieven ^a,b   Sifrim, Daniel ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bronchial aspiration; Bronchiolitis obliterans syndrome; Gastroesophageal reflux; Lung transplantation

Indexed keywords

AZITHROMYCIN; BACLOFEN; BILE ACID; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; INTERLEUKIN 8; METOCLOPRAMIDE; PEPSIN A; PROTON PUMP INHIBITOR;

ACID ASPIRATION; ANTIREFLUX OPERATION; BRONCHIOLITIS OBLITERANS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; EPITHELIUM CELL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL REFLUX; HUMAN; LUNG CLEARANCE; LUNG DISEASE; LUNG FUNCTION; LUNG TRANSPLANTATION; NAUSEA; PATHOGENESIS; PREVALENCE; REGULATORY MECHANISM; REVIEW; SEDATION; SIDE EFFECT; VAGUS REFLEX;

BRONCHIOLITIS OBLITERANS; GASTROESOPHAGEAL REFLUX; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; RESPIRATORY ASPIRATION; SURVIVAL RATE; SYNDROME;

EID: 77956362368     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-010-0106-3     Document Type: Review

References (64)

1. Christie JD, Edwards LB, Aurora P, et al.: Registry of the International Society for Heart and Lung Transplantation: twentyfifth official adult lung and heart/lung transplantation report- 2008. J Heart Lung Transplant 2008, 27:957-969.
2. Blondeau K, Mertens V, Vanaudenaerde BA, et al.: Gastrooesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008, 31:707-713. This paper concluded that lung transplant patients with BOS did not have particularly higher reflux indices. Bile acids in BALF might be associated with the development of BOS. Treating patients with PPI therapy does not protect patients from aspirating gastric contents and probably will not prevent the development of BOS.
3. D'Ovidio F, Keshavjee S: Gastroesophageal reflux and lung transplantation. Dis Esophagus 2006, 19:315-320.
4. Hadjiliadis D, Duane DR, Steele MP, et al.: Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003, 17:363-368.
5. Young LR, Hadjiliadis D, Davis RD, Palmer SM: Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003, 124:1689-1693.
6. Blondeau K, Mertens V, Vanaudenaerde BA, et al.: Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant 2009, 28:141-148. This study shows that presence of bile acids in BALF was associated with increased volume exposure and the number of weakly acidic reflux events during the night. These results should be taken into account when adopting diagnostic and therapeutic strategies to protect the patient from aspiration of bile acids into the lungs.
7. D'Ovidio F, Mura M, Ridsdale R, et al.: The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 2006, 6:1930-1938.
8. Robertson AG, Ward C, Pearson JP, et al.: Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation. Thorax 2009, 64:1005-1007.
9. Benden C, Aurora P, Curry J, et al.: High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005, 40:68-71.
10. Button BM, Roberts S, Kotsimbos TC, et al.: Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J Heart Lung Transplant 2005, 24:1522-1529.
11. D'Ovidio F, Mura M, Tsang M, et al.: Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005, 129:1144-1152.
12. Stovold R, Forrest IA, Corris PA, et al.: Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med 2007, 175:1298-1303.
13. Ward C, Forrest IA, Brownlee IA, et al.: Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005, 60:872-874.
14. Mertens V, Blondeau K, Vanaudenaerde B, et al.: Pepsin or bile acids: what is the best marker of gastric aspiration in lung transplant recipients? J Heart Lung Transplant 2008, 27:S125-S126.
15. Verleden GM: Chronic allograft rejection (obliterative bronchiolitis). Semin Respir Crit Care Med 2001, 22:551-558.
16. Morrish WF, Herman SJ, Weisbrod GL, Chamberlain DW: Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high-resolution CT. The Toronto Lung Transplant Group. Radiology 1991, 179:487-490.
17. Skeens JL, Fuhrman CR, Yousem SA: Bronchiolitis obliterans in heart-lung transplantation patients: radiologic findings in 11 patients. AJR Am J Roentgenol 1989, 153:253-256.
18. Hachem RR, Khalifah AP, Chakinala MM, et al.: The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005, 80:1406-1413.
19. Husain AN, Siddiqui MT, Holmes EW, et al.: Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999, 159:829-833.
20. Paul LC: Current knowledge of the pathogenesis of chronic allograft dysfunction. Transplant Proc 1999, 31:1793-1795.
21. Cooper JD, Billingham M, Egan T, et al.: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993, 12:713-716.
22. Estenne M, Maurer JR, Boehler A, et al.: Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002, 21:297-310.
23. Boehler A, Estenne M: Obliterative bronchiolitis after lung transplantation. Curr Opin Pulm Med 2000, 6:133-139.
24. Raghu G, Freudenberger TD, Yang S, et al.: High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006, 27:136-142.
25. Salvioli B, Belmonte G, Stanghellini V, et al.: Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 2006, 38:879-884.
26. Sweet MP, Patti MG, Leard LE, et al.: Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg 2007, 133:1078-1084.
27. Tobin RW, Pope CE, Pellegrini CA, et al.: Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 158:1804-1808.
28. Kempainen RR, Savik K, Whelan TP, et al.: High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest 2007, 131:1666-1671.
29. Sweet MP, Patti MG, Hoopes C, et al.: Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax 2009, 64:167-173.
30. Au J, Hawkins T, Venables C, et al.: Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg 1993, 55:94-97.
31. Berkowitz N, Schulman LL, McGregor C, Markowitz D: Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest 1995, 108:1602-1607.
32. Cantu E, III, Appel JZ, III, Hartwig MG, et al.: J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004, 78:1142-1151.
33. D'Ovidio F, Singer LG, Hadjiliadis D, et al.: Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg 2005, 80:1254-1260.
34. Kirk AJ, Colquhoun IW, Corris PA, et al.: Impaired gastrointestinal motility in pulmonary transplantation. Lancet 1990, 336:752.
35. Lubetkin EI, Lipson DA, Palevsky HI, et al.: GI complications after orthotopic lung transplantation. Am J Gastroenterol 1996, 91:2382-2390.
36. Reid KR, McKenzie FN, Menkis AH, et al.: Importance of chronic aspiration in recipients of heart-lung transplants. Lancet 1990, 336:206-208.
37. Logan AJ, Morris-Stiff GJ, Bowrey DJ, Jurewicz WA: Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study. Clin Transplant 2002, 16:163-167.
38. Kasapidis P, Vassilakis JS, Tzovaras G, et al.: Effect of hiatal hernia on esophageal manometry and pH-metry in gastroesophageal reflux disease. Dig Dis Sci 1995, 40:2724-2730.
39. Halsey KD, Wald A, Meyer KC, et al.: Non-acidic supraesophageal reflux associated with diffuse alveolar damage and allograft dysfunction after lung transplantation: a case report. J Heart Lung Transplant 2008, 27:564-567.
40. Fass R, Achem SR, Harding S, et al.: Review article: supraoesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux. Aliment Pharmacol Ther 2004, 20 Suppl 9:26-38.
41. Gotley DC, Morgan AP, Ball D, et al.: Composition of gastrooesophageal refluxate. Gut 1991, 32:1093-1099.
42. Mertens V, Blondeau K, Pauwels A, et al.: Effect of gastric juice from patients "on"acid supressive therapy (PPI) on human bronchial epithelial cells. J Heart Lung Transplant 2009, 28:S212.
43. Duarte AG, Terminella L, Smith JT, et al.: Restoration of cough reflex in lung transplant recipients. Chest 2008, 134:310-316. Lung transplantation involves vagal nerve interruption, resulting in sensory airway denervation and impairment of the cough reflex. This paper shows that in human lung transplant recipients, recovery of the cough reflex was noted 12 months after lung transplantation.
44. Hathaway TJ, Higenbottam TW, Morrison JF, et al.: Effects of inhaled capsaicin in heart-lung transplant patients and asthmatic subjects. Am Rev Respir Dis 1993, 148:1233-1237.
45. Ferrari M, Olivieri M, Sembenini C, et al.: Tussive effect of capsaicin in patients with gastroesophageal reflux without cough. Am J Respir Crit Care Med 1995, 151(2 Pt 1):557-561.
46. Ing AJ, Ngu MC, Breslin AB: Chronic persistent cough and gastro-oesophageal reflux. Thorax 1991, 46:479-483.
47. Wright RA, Miller SA, Corsello BF: Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology 1990, 99:71-73.
48. Nunley DR, Gal AA, Vega JD, et al.: Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002, 122:1185-1191.
49. Vos R, Vanaudenaerde BM, Dupont LJ, et al.: Transient airway colonization is associated with airway inflammation after lung transplantation. Am J Transplant 2007, 7:1278-1287.
50. Vos R, Blondeau K, Vanaudenaerde BM, et al.: Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J Heart Lung Transplant 2008, 27:843-849.
51. Wright JR: Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005, 5:58-68.
52. Effros RM, Jacobs ER, Schapira RM, Biller J: Response of the lungs to aspiration. Am J Med 2000, 108(Suppl 4a):15S-19S.
53. Johnston N, Wells CW, Samuels TL, Blumin JH: Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol 2009, 118:677-685.
54. Davis RD Jr, Lau CL, Eubanks S, et al.: Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003, 125:533-542.
55. Fink SM, Lange RC, McCallum RW: Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients. Dig Dis Sci 1983, 28:1057-1061.
56. Mansi C, Borro P, Giacomini M, et al.: Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000, 14:561-569.
57. Takeda T, Konomi H, Naritomi G, et al.: Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study. J Gastroenterol 1996, 31:323-328.
58. Netzer P, Schmitt B, Inauen W: Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002, 16:1481-1490.
59. Mertens V, Blondeau K, Pauwels A, et al.: Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci 2009, 54:972-979. Azithromycin improves lung function in some patients with BOS after lung transplantation, and this improvement has been attributed to an immunomodulatory effect. This study shows that lung transplant patients on azithromycin have less GER and bile acid aspiration. This effect might be due to enhanced esophageal motility and accelerated gastric emptying induced by azithromycin.
60. Vela MF, Tutuian R, Katz PO, Castell DO: Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003, 17:243-251.
61. Koek GH, Sifrim D, Lerut T, et al.: Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastrooesophageal reflux refractory to proton pump inhibitors. Gut 2003, 52:1397-1402.
62. Lau CL, Palmer SM, Howell DN, et al.: Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002, 16:1674-1678.
63. O'Halloran EK, Reynolds JD, Lau CL, et al.: Laparoscopic Nissen fundoplication for treating reflux in lung transplant recipients. J Gastrointest Surg 2004, 8:132-137.
64. Palmer SM, Miralles AP, Howell DN, et al.: Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000, 118:1214-1217.